{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:04:45Z","timestamp":1786982685110,"version":"build-2736575974"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T00:00:00Z","timestamp":1636070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T00:00:00Z","timestamp":1636070400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CEN Case Rep"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1007\/s13730-021-00658-y","type":"journal-article","created":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T13:02:27Z","timestamp":1636117347000},"page":"225-230","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Complete remission of tip lesion variant focal segmental glomerulosclerosis (FSGS) with the Janus Kinase (JAK) inhibitor tofacitinib"],"prefix":"10.1007","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6007-5344","authenticated-orcid":false,"given":"Martin","family":"Sedlacek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason R.","family":"Pettus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,5]]},"reference":[{"issue":"2","key":"658_CR1","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/nrneph.2014.216","volume":"11","author":"AB Fogo","year":"2015","unstructured":"Fogo AB. Causes and pathogenesis of focal segmental glomerulosclerosis. Nat Rev Nephrol. 2015;11(2):76\u201387. https:\/\/doi.org\/10.1038\/nrneph.2014.216 (PMID: 25447132; PMCID: PMC4772430).","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"658_CR2","doi-asserted-by":"publisher","first-page":"626","DOI":"10.2215\/CJN.05810513","volume":"9","author":"B Bose","year":"2014","unstructured":"Bose B, Cattran D, Toronto Glomerulonephritis Registry. Glomerular diseases: FSGS. Clin J Am Soc Nephrol. 2014;9(3):626\u201332. https:\/\/doi.org\/10.2215\/CJN.05810513 (PMID: 23990165).","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"658_CR3","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.kint.2018.05.022","volume":"94","author":"PMJ Tao","year":"2018","unstructured":"Tao PMJ, Mariani L, Eddy S, Maecker H, Kambham N, Mehta K, Hartman J, Wang W, Kretzler M, Lafayette RA. JAK-STAT signaling is activated in the kidney and peripheral blood cells of patients with focal segmental glomerulosclerosis. Kidney Int. 2018;94(4):795\u2013808. https:\/\/doi.org\/10.1016\/j.kint.2018.05.022 (PMID: 30093081; PMCID: PMC6744284).","journal-title":"Kidney Int"},{"issue":"3","key":"658_CR4","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1080\/14728214.2020.1803276","volume":"25","author":"H Trachtman","year":"2020","unstructured":"Trachtman H. Emerging drugs for treatment of focal segmental glomerulosclerosis. Expert Opin Emerg Drugs. 2020;25(3):367\u201375. https:\/\/doi.org\/10.1080\/14728214.2020.1803276 (PMID: 32729368; PMCID: PMC7508791).","journal-title":"Expert Opin Emerg Drugs"},{"issue":"12","key":"658_CR5","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/nrd.2017.201","volume":"16","author":"DM Schwartz","year":"2017","unstructured":"Schwartz DM, Kanno Y, Villarino A, Ward M, Gadina M, O\u2019Shea JJ. JAK inhibition as a therapeutic strategy for immune and inflammatory diseases. Nat Rev Drug Discov. 2017;16(12):843\u201362. https:\/\/doi.org\/10.1038\/nrd.2017.201 (PMID: 29104284).","journal-title":"Nat Rev Drug Discov"},{"issue":"11","key":"658_CR6","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1681\/ASN.2012040389","volume":"23","author":"SM Korbet","year":"2012","unstructured":"Korbet SM. Treatment of primary FSGS in adults. J Am Soc Nephrol. 2012;23(11):1769\u201376. https:\/\/doi.org\/10.1681\/ASN.2012040389 (PMID: 22997260).","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"658_CR7","doi-asserted-by":"publisher","first-page":"e55","DOI":"10.1053\/j.ajkd.2005.05.034","volume":"46","author":"I Sekhon","year":"2005","unstructured":"Sekhon I, Munjal S, Croker B, Johnson RJ, Ejaz AA. Glomerular tip lesion associated with nonsteroidal anti-inflammatory drug-induced nephrotic syndrome. Am J Kidney Dis. 2005;46(4):e55\u20138. https:\/\/doi.org\/10.1053\/j.ajkd.2005.05.034 (PMID: 16183408).","journal-title":"Am J Kidney Dis"},{"key":"658_CR8","doi-asserted-by":"publisher","DOI":"10.1007\/s40620-020-00837-7","author":"SZMWH Oo","year":"2020","unstructured":"Oo SZMWH, Freese ME, Holanda DG, Thomas CP. Spontaneous remission of genetic, apparent primary, FSGS presenting with nephrotic syndrome challenges traditional notions of primary FSGS. J Nephrol. 2020. https:\/\/doi.org\/10.1007\/s40620-020-00837-7 (PMID: 32852700).","journal-title":"J Nephrol"},{"issue":"5","key":"658_CR9","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1053\/j.ackd.2019.08.011","volume":"26","author":"N Oliva-Damaso","year":"2019","unstructured":"Oliva-Damaso N, Payan J, Oliva-Damaso E, Pereda T, Bomback AS. Lupus podocytopathy: an overview. Adv Chronic Kidney Dis. 2019;26(5):369\u201375. https:\/\/doi.org\/10.1053\/j.ackd.2019.08.011 (PMID: 31733721).","journal-title":"Adv Chronic Kidney Dis"},{"issue":"9","key":"658_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102612","volume":"19","author":"L Antonini","year":"2020","unstructured":"Antonini L, Le Mauff B, Marcelli C, Aouba A, de Boysson H. Rhupus: a systematic literature review. Autoimmun Rev. 2020;19(9): 102612. https:\/\/doi.org\/10.1016\/j.autrev.2020.102612 (PMID: 32668290).","journal-title":"Autoimmun Rev"},{"issue":"10","key":"658_CR11","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1177\/0961203320938456","volume":"29","author":"B Frade-Sosa","year":"2020","unstructured":"Frade-Sosa B, Narv\u00e1ez J, Salman-Monte TC, Castellanos-Moreira R, Ortiz-Santamaria V, Torrente-Segarra V, Castellvi I, Magallares B, Reina D, Minguez S, Sall\u00e9s M, de Manrique LMG, Ordo\u00f1ez S, Riera E, Schur PH, G\u00f3mez-Puerta JA. A comparative study on clinical and serological characteristics between patients with rhupus and those with systemic lupus erythematosus and rheumatoid arthritis. Lupus. 2020;29(10):1216\u201326. https:\/\/doi.org\/10.1177\/0961203320938456 (PMID: 32631205).","journal-title":"Lupus"},{"issue":"6","key":"658_CR12","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.jbspin.2020.05.010","volume":"87","author":"C Garufi","year":"2020","unstructured":"Garufi C, Mancuso S, Spinelli FR, Truglia S, Ceccarelli F, Alessandri C, Conti F. Janus kinases inhibitors for treating patients with rhupus. Joint Bone Spine. 2020;87(6):673\u20134. https:\/\/doi.org\/10.1016\/j.jbspin.2020.05.010 (PMID: 32534202).","journal-title":"Joint Bone Spine"},{"issue":"4","key":"658_CR13","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.rdc.2018.06.008","volume":"44","author":"T Kapoor","year":"2018","unstructured":"Kapoor T, Bathon J. Renal manifestations of rheumatoid arthritis. Rheum Dis Clin N Am. 2018;44(4):571\u201384. https:\/\/doi.org\/10.1016\/j.rdc.2018.06.008 (PMID: 30274624).","journal-title":"Rheum Dis Clin N Am"},{"issue":"1","key":"658_CR14","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1097\/MNH.0000000000000079","volume":"24","author":"FC Brosius 3rd","year":"2015","unstructured":"Brosius FC 3rd, He JC. JAK inhibition and progressive kidney disease. Curr Opin Nephrol Hypertens. 2015;24(1):88\u201395. https:\/\/doi.org\/10.1097\/MNH.0000000000000079 (PMID:25415616;PMCID:PMC4673981).","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"11","key":"658_CR15","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1093\/ndt\/gfx377","volume":"33","author":"KR Tuttle","year":"2018","unstructured":"Tuttle KR, Brosius FC 3rd, Adler SG, Kretzler M, Mehta RL, Tumlin JA, Tanaka Y, Haneda M, Liu J, Silk ME, Cardillo TE, Duffin KL, Haas JV, Macias WL, Nunes FP, Janes JM. JAK1\/JAK2 inhibition by baricitinib in diabetic kidney disease: results from a Phase 2 randomized controlled clinical trial. Nephrol Dial Transpl. 2018;33(11):1950\u20139. https:\/\/doi.org\/10.1093\/ndt\/gfx377 (PMID:29481660;PMCID:PMC6212720).","journal-title":"Nephrol Dial Transpl"},{"issue":"4","key":"658_CR16","first-page":"683","volume":"36","author":"T Watanabe","year":"2018","unstructured":"Watanabe T, Hattori T, Ogawa Y, Jodo S. Successful treatment with tofacitinib for renal disorder due to amyloid A amyloidosis and immunoglobulin A nephropathy in a patient with rheumatoid arthritis. Clin Exp Rheumatol. 2018;36(4):683\u20134.","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"658_CR17","doi-asserted-by":"publisher","first-page":"817","DOI":"10.2169\/internalmedicine.3668-19","volume":"59","author":"I Itoh","year":"2020","unstructured":"Itoh I, Kasuno K, Yamamoto C, Takahashi N, Shimizu H, Ojima T, Hayashi S, Kimura H, Iwano M. IgA vasculitis developed as an adverse effect of tofacitinib taken for rheumatoid arthritis. Intern Med. 2020;59(6):817\u201321. https:\/\/doi.org\/10.2169\/internalmedicine.3668-19 (PMID: 31813912; PMCID: PMC7118374).","journal-title":"Intern Med"},{"issue":"6","key":"658_CR18","doi-asserted-by":"publisher","first-page":"F1151","DOI":"10.1152\/ajprenal.00034.2019","volume":"316","author":"J Pace","year":"2019","unstructured":"Pace J, Paladugu P, Das B, He JC, Mallipattu SK. Targeting STAT3 signaling in kidney disease. Am J Physiol Renal Physiol. 2019;316(6):F1151\u201361. https:\/\/doi.org\/10.1152\/ajprenal.00034.2019 (PMID: 30943069; PMCID: PMC6620596).","journal-title":"Am J Physiol Renal Physiol"}],"container-title":["CEN Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-021-00658-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13730-021-00658-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-021-00658-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T09:19:30Z","timestamp":1651483170000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13730-021-00658-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,5]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["658"],"URL":"https:\/\/doi.org\/10.1007\/s13730-021-00658-y","relation":{},"ISSN":["2192-4449"],"issn-type":[{"value":"2192-4449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,5]]},"assertion":[{"value":"8 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have declared that no conflict of interest exists.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"Informed consent was obtained from the patient whose case is reported in this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}